Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$321K Buy
2,497
+400
+19% +$46.8K 0.15% 189
2026
Q1
$252K Sell
2,097
-9,183
-81% -$1.06M 0.17% 164
2025
Q4
$323K Buy
+11,280
New +$1.06M 0.22% 121
2024
Q3
– Sell
-1,653
Closed -$207K – 150
2024
Q2
$207K Sell
1,653
-746
-31% -$96.1K 0.22% 127
2024
Q1
$317K Buy
2,399
+402
+20% +$49.5K 0.34% 85
2023
Q4
$218K Buy
+1,997
New +$207K 0.27% 109

Other funds holding MRK

FSA Advisors's MRK Position: Q2 2026 in Review

FSA Advisors increased its Merck (MRK) stake by 19% in Q2 2026, buying an estimated $46.8K and bringing the position to 2,497 shares worth $321K. The position accounts for 0.15% of the portfolio, ranked #189.

FSA Advisors first reported a position in MRK in Q4 2023 and has held it in 6 quarters since. The position peaked at $323K in Q4 2025. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • FSA Advisors held 2,497 shares of Merck worth $321K as of Q2 2026.
  • FSA Advisors bought 400 Merck shares in Q2 2026, an estimated $46.8K.
  • Merck made up 0.15% of FSA Advisors's portfolio in Q2 2026, its #189 holding.
  • FSA Advisors first reported a position in Merck in Q4 2023 and has held it in 6 quarters since.
  • FSA Advisors's Merck position peaked at $323K in Q4 2025.
  • 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on FSA Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.